CClinicalTrials.gg
RecruitingNCT07279480Updated Dec 12, 2025

Communication and Health Investments for Elderly Women

An interventional study of Tell both and Free Transport in Take-up of Preventative Care and Communication About Health Information, sponsored by Abdul Latif Jameel Poverty Action Lab. Recruiting at 1 site in India. Open to female participants aged 60 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-12.

Sponsored by Abdul Latif Jameel Poverty Action Lab · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Nov 2025; still recruiting 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
1,200
Allocation
Randomized
Ages
60 Years to 75 Years
Sex
Female
01

Study summary

This study investigates how household communication plays a role in elderly women's take-up of health check-ups in rural Tamil Nadu, India. First, we survey elders and their caretakers to measure demand for check-ups for elders. We measure how interest in check-ups changes when we offer different versions of transportation support, to understand how much interest in check-ups are affected by the degree of caretaker involvement required. Second, we conduct a randomized evaluation of interventions to improve take-up of free health check-ups at a nearby private hospital. We will cross-randomize two interventions. The first randomizes who is informed about the check-up: either only the elder is informed or both the elder and the caretaker are informed about the check-up. The second randomizes whether free transportation is provided to and from the check-up. We will measure take-up of the check-up. We will also measure elders' willingness to mention the check-up to the caretaker.

02

Conditions studied

  • Take-up of Preventative Care
  • Communication About Health Information

Keywords

  • Elderly women
  • India
  • Household communication
  • Preventative health
03

In context

Lead sponsor

Abdul Latif Jameel Poverty Action Lab is the lead sponsor of 13 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Elderly women aged 60-75

Exclusion criteria

Exclusion Criteria:

  • Those with severe hearing, speech, mental, or mobility impairment
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
1,200 participants (estimated)

Study arms

  • No intervention
    Tell elder only, without transport (Control)

    Elder is informed about the check-up. No free arranged transportation offered.

  • Experimental
    Tell elder only, with free transport

    Elder is informed about the check-up. We offer to arrange private transportation to and from the hospital at no cost.

    Behavioral: Free Transport

  • Experimental
    Tell elder and caretaker, without transport

    Both elder and the caretaker are directly informed about the check-up. No free arranged transportation offered.

    Behavioral: Tell both

  • Experimental
    Tell elder and caretaker, with free transport

    We offer to arrange private transportation to and from the hospital at no cost.

    Behavioral: Tell both · Behavioral: Free Transport

Interventions

  • BehavioralTell both

    Both elder and the caretaker are directly informed about the check-up.

  • BehavioralFree Transport

    We offer to arrange private transportation to and from the hospital at no cost.

06

What researchers measure

Primary outcomes

  1. Sign-up rates for check-up.

    This will be a measure of whether the elder is signed up for the check-up by the caretaker. This will be measured either when the caretaker calls to reserve a spot for the elder or when the research team follows up with the household before the check-up.

    Time frame: Assessed at 3 days after the intervention

Secondary outcomes

  1. Elder attendance at check-up.

    This is a measure of whether the elder shows up to the health check-up at the end of the week. Attendance at the health check-up will be measured by surveyors at the hospital, about 1 week after the health check-up invitations are shared with households.

    Time frame: 1 week after the intervention

  2. Elder willingness to mention check-up to caretaker

    This is a measure of whether elder chooses to mention check-up to caretaker when offered. Among elders in households that are randomized into the "Tell elder only" arm, we will offer to inform the caretaker of the check-up on behalf of the elder and record whether the elder was willing to have us mention the check-up as one of our outcomes.

    Time frame: Assessed 2 days after the intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07279480
Lead sponsor
Abdul Latif Jameel Poverty Action Lab
Responsible party
Sponsor
First posted
Dec 12, 2025
Start date
Nov 10, 2025
Primary completion
Aug 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Dec 12, 2025

Study contacts

Jenny Wang
Contact
wangjm@mit.edu
617-253-3807

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion